Concord Drugs Ltd

NSE: CONCORD · BSE: 538965 · Pharmaceuticals & Biotechnology · 15 announcements

Share price

₹72.50

Market cap

₹95.52 Cr

Revenue (annual)

₹78.74 Cr

Net profit (annual)

₹1.06 Cr

P/E (TTM)

46.6×Sector 47.4×

Promoter holding

45.08%-9.31% QoQ

FII holding

0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.